Search research articles
Contact Us
Filters
Showing results (151-160 of 199) with videos related to
Page
of 20
Sort By:
Mini Reviews in Medicinal Chemistry
|
February 21, 2014
From pyridinium-based to centrally active acetylcholinesterase reactivators
Jan Korabecny, Ondrej Soukup, Rafael Dolezal, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
September 18, 2023
BODIPY-labelled acetylcholinesterase reactivators can be encapsulated into ferritin nanovehicles for enhanced bioavailability in the CNS
Eliska Prchalova, Martina Sukupova, David Malinak, et al.
Chemico-Biological Interactions
|
November 6, 2025
Reactivation screening of A-234-inhibited human recombinant acetylcholinesterase in vitro
Jakub Opravil, Jaroslav Pejchal, Martina Hrabinova, et al.
Archives of Toxicology
|
September 10, 2020
An update on T-2 toxin and its modified forms: metabolism, immunotoxicity mechanism, and human exposure assessment
Qinghua Wu, Zihui Qin, Kamil Kuca, et al.
Molecular Medicine Reports
|
February 24, 2023
STAT3 inhibitor Stattic and its analogues inhibit STAT3 phosphorylation and modulate cytokine secretion in senescent tumour cells
Romana Mikyskova, Olena Sapega, Miroslav Psotka, et al.
ACS Medicinal Chemistry Letters
|
December 20, 2023
Nanomolar Benzothiazole-Based Inhibitors of 17β-HSD10 with Cellular Bioactivity
Michaela Hanzlova, Marketa Sedlacek Miskerikova, Aneta Rotterova, et al.
Molecules (Basel, Switzerland)
|
December 4, 2010
Synthesis and in vitro evaluation of N-(Bromobut-3-en-2-yl)-7-methoxy-1,2,3,4-tetrahydroacridin-9-amine as a cholinesterase inhibitor with regard to Alzheimer's disease treatment
Jan Korabecny, Kamil Musilek, Ondrej Holas, et al.
Drug Development Research
|
July 6, 2026
Design, Synthesis, and Biological Evaluation of Chiral Urea and Thiourea Derivatives as Multitarget-Directed Anti-Alzheimer Agents
Sule Erol Gunal, Senel Teke Tuncel, İlke Demir, et al.
ACS Medicinal Chemistry Letters
|
January 16, 2020
Cysteine-Targeted Insecticides against <i>A. gambiae</i> Acetylcholinesterase Are Neither Selective nor Reversible Inhibitors
Lukas Gorecki, Rudolf Andrys, Monika Schmidt, et al.
Medicinal Chemistry (Shariqah (United Arab Emirates))
|
January 10, 2017
6-benzothiazolyl ureas, thioureas and guanidines are potent inhibitors of ABAD/17β-HSD10 and potential drugs for Alzheimer's disease treatment: Design, synthesis and in vitro evaluation
Ondrej Benek, Lukas Hroch, Laura Aitken, et al.
Page
of 20
Search research articles
Search
Showing results (151-160 of 199) with videos related to
Sort By:
Page
of 20
Mini Reviews in Medicinal Chemistry
|
February 21, 2014
From pyridinium-based to centrally active acetylcholinesterase reactivators
Jan Korabecny, Ondrej Soukup, Rafael Dolezal, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
September 18, 2023
BODIPY-labelled acetylcholinesterase reactivators can be encapsulated into ferritin nanovehicles for enhanced bioavailability in the CNS
Eliska Prchalova, Martina Sukupova, David Malinak, et al.
Chemico-Biological Interactions
|
November 6, 2025
Reactivation screening of A-234-inhibited human recombinant acetylcholinesterase in vitro
Jakub Opravil, Jaroslav Pejchal, Martina Hrabinova, et al.
Archives of Toxicology
|
September 10, 2020
An update on T-2 toxin and its modified forms: metabolism, immunotoxicity mechanism, and human exposure assessment
Qinghua Wu, Zihui Qin, Kamil Kuca, et al.
Molecular Medicine Reports
|
February 24, 2023
STAT3 inhibitor Stattic and its analogues inhibit STAT3 phosphorylation and modulate cytokine secretion in senescent tumour cells
Romana Mikyskova, Olena Sapega, Miroslav Psotka, et al.
ACS Medicinal Chemistry Letters
|
December 20, 2023
Nanomolar Benzothiazole-Based Inhibitors of 17β-HSD10 with Cellular Bioactivity
Michaela Hanzlova, Marketa Sedlacek Miskerikova, Aneta Rotterova, et al.
Molecules (Basel, Switzerland)
|
December 4, 2010
Synthesis and in vitro evaluation of N-(Bromobut-3-en-2-yl)-7-methoxy-1,2,3,4-tetrahydroacridin-9-amine as a cholinesterase inhibitor with regard to Alzheimer's disease treatment
Jan Korabecny, Kamil Musilek, Ondrej Holas, et al.
Drug Development Research
|
July 6, 2026
Design, Synthesis, and Biological Evaluation of Chiral Urea and Thiourea Derivatives as Multitarget-Directed Anti-Alzheimer Agents
Sule Erol Gunal, Senel Teke Tuncel, İlke Demir, et al.
ACS Medicinal Chemistry Letters
|
January 16, 2020
Cysteine-Targeted Insecticides against <i>A. gambiae</i> Acetylcholinesterase Are Neither Selective nor Reversible Inhibitors
Lukas Gorecki, Rudolf Andrys, Monika Schmidt, et al.
Medicinal Chemistry (Shariqah (United Arab Emirates))
|
January 10, 2017
6-benzothiazolyl ureas, thioureas and guanidines are potent inhibitors of ABAD/17β-HSD10 and potential drugs for Alzheimer's disease treatment: Design, synthesis and in vitro evaluation
Ondrej Benek, Lukas Hroch, Laura Aitken, et al.
Page
of 20